company background image
HEXO logo

HEXO NasdaqCM:HEXO Stock Report

Last Price

US$0.71

Market Cap

US$30.4m

7D

-5.3%

1Y

-78.9%

Updated

23 Jun, 2023

Data

Company Financials +

HEXO Corp.

NasdaqCM:HEXO Stock Report

Market Cap: US$30.4m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

HEXO Stock Overview

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. More details

HEXO fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Rewards

Trading at 87.9% below our estimate of its fair value

Trading at good value compared to peers and industry

Risk Analysis

Shareholders have been diluted in the past year

Does not have a meaningful market cap ($40M)

Currently unprofitable and not forecast to become profitable over the next 3 years

Volatile share price over the past 3 months


My Notes

Capture your thoughts, links and company narrative

HEXO Corp. Competitors

Cumberland Pharmaceuticals

NasdaqGS:CPIX

US$32.3m

Nutriband

NasdaqCM:NTRB

US$56.3m

Aytu BioPharma

NasdaqCM:AYTU

US$10.9m

IGC Pharma

NYSEAM:IGC

US$27.6m

Price History & Performance

Summary of share price highs, lows and changes for HEXO
Historical stock prices
Current Share PriceCA$0.71
52 Week HighCA$3.84
52 Week LowCA$0.66
Beta2.13
1 Month Change-42.74%
3 Month Change-45.38%
1 Year Change-78.85%
3 Year Change-98.17%
5 Year Change-99.68%
Change since IPO-99.15%

Recent News & Updates

Recent updates

Hexo to produce Mike Tyson's cannabis brand's products in Canada

Aug 30

Canopy Growth, Tilray other Canadian cannabis names up amid WallStreetBets chatter

Aug 17

HEXO receives additional 180 calendar day grace period for regaining compliance

Jul 28

HEXO wins shareholder approval for note transaction with Tilray

Jul 05

HEXO: Undervalued, But With Certain Dilution Risks

Apr 28

HEXO Q1 Earnings: Not A Great Path Forward

Dec 14

Shareholder Returns

HEXOUS PharmaceuticalsUS Market
7D-5.3%-0.6%-0.2%
1Y-78.9%3.0%25.8%

Return vs Industry: HEXO underperformed the US Pharmaceuticals industry which returned -1.9% over the past year.

Return vs Market: HEXO underperformed the US Market which returned 9.1% over the past year.

Price Volatility

Is HEXO's price volatile compared to industry and market?
HEXO volatility
HEXO Average Weekly Movement15.2%
Pharmaceuticals Industry Average Movement10.8%
Market Average Movement6.4%
10% most volatile stocks in US Market18.6%
10% least volatile stocks in US Market3.1%

Stable Share Price: HEXO's share price has been volatile over the past 3 months.

Volatility Over Time: HEXO's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2013n/aCharlie Bowmanwww.hexocorp.com

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names.

HEXO Corp. Fundamentals Summary

How do HEXO's earnings and revenue compare to its market cap?
HEXO fundamental statistics
Market capUS$30.45m
Earnings (TTM)-US$207.74m
Revenue (TTM)US$94.37m

0.3x

P/S Ratio

-0.1x

P/E Ratio

Is HEXO overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HEXO income statement (TTM)
RevenueCA$124.10m
Cost of RevenueCA$192.65m
Gross Profit-CA$68.55m
Other ExpensesCA$204.64m
Earnings-CA$273.18m

Last Reported Earnings

Apr 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-6.21
Gross Margin-55.23%
Net Profit Margin-220.13%
Debt/Equity Ratio124.7%

How did HEXO perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/23 04:25
End of Day Share Price 2023/06/22 00:00
Earnings2023/04/30
Annual Earnings2022/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

HEXO Corp. is covered by 23 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aaron GreyAlliance Global Partners
David KideckelATB Capital Markets
Doug CooperBeacon Securities Limited